Krystal Biotech Inc
NASDAQ:KRYS

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
NASDAQ:KRYS
Watchlist
Price: 234.13 USD 5.48% Market Closed
Market Cap: 6.8B USD

Wall Street
Price Targets

KRYS Price Targets Summary
Krystal Biotech Inc

Wall Street analysts forecast KRYS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KRYS is 226.9 USD with a low forecast of 199.98 USD and a high forecast of 267.75 USD.

Lowest
Price Target
199.98 USD
15% Downside
Average
Price Target
226.9 USD
3% Downside
Highest
Price Target
267.75 USD
14% Upside
Krystal Biotech Inc Competitors:
Price Targets
COV
Covalon Technologies Ltd
99% Upside
2171
CARsgen Therapeutics Holdings Ltd
27% Upside
688520
Sinocelltech Group Ltd
22% Upside
GYRE
Gyre Therapeutics Inc
130% Upside
CVAC
CureVac NV
7% Downside
688235
Beigene Ltd
32% Upside
CSL
CSL Ltd
36% Upside
EXAS
Exact Sciences Corp
0% Downside

Revenue
Forecast

Revenue Estimate
Krystal Biotech Inc

The compound annual growth rate of Krystal Biotech Inc's revenue for the next 3 years is 37%.

N/A
Past Growth
37%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Krystal Biotech Inc

The compound annual growth rate of Krystal Biotech Inc's operating income for the next 3 years is 52%.

N/A
Past Growth
52%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Krystal Biotech Inc

The compound annual growth rate of Krystal Biotech Inc's net income for the next 3 years is 45%.

N/A
Past Growth
45%
Estimated Growth
Estimates Accuracy
-39%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KRYS's stock price target?
Price Target
226.9 USD

According to Wall Street analysts, the average 1-year price target for KRYS is 226.9 USD with a low forecast of 199.98 USD and a high forecast of 267.75 USD.

What is Krystal Biotech Inc's Revenue forecast?
Projected CAGR
37%

The compound annual growth rate of Krystal Biotech Inc's revenue for the next 3 years is 37%.

What is Krystal Biotech Inc's Operating Income forecast?
Projected CAGR
52%

The compound annual growth rate of Krystal Biotech Inc's operating income for the next 3 years is 52%.

What is Krystal Biotech Inc's Net Income forecast?
Projected CAGR
45%

The compound annual growth rate of Krystal Biotech Inc's net income for the next 3 years is 45%.

Back to Top